Study director and workpackage owner in research and drug development projectsInternal Disease Area Expert (asthma)Project manager of an international collaborative research project and scientific lead coordinating activities within five work packagesAmbassador of the Research Department to support Global Medical Affairs in customer relations. Presentations to KOLs and customers in English, Swedish or German language.

Senior research scientist at Astra Zeneca, Mölndal, Sweden within Innovative Medicines, Division of Respiratory, Immunology, and Autoimmunity (RIA), Integrative Pharmacology Section>> Development of new pharmaceuticals for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosisPrinciple tasks:- Project leader during identification and validation of a new immunomodulatory target for the treatment of COPD by enhancing regulatory macrophages (target champion for pre-TSID project). Responsible for all conceptual work and organization as well as for the scientific rational behind the target idea. Coordination of a multidisciplinary international team of biologists, chemists, toxicologists and physicians and external cooperation partners. - Contribution with theoretical and hands-on expertise in the area of lung physiology and preclinical asthma models

Research scientist at ALK-Abello, Horsholm, Denmark, within the in vivo team, headed by Carola Rask (2 months project employment during April and May)>> The project dealt with the characterization of mechanisms of hyposensitization and allergy vaccines, with emphasis on changes of lung function in preclinical modelsPrinciple tasks:- Installation, implementation and validation of the FlexiVent technique and its SOP- Education and practical training of colleagues in the FlexiVent FX and software- Investigations into the prophylactic effects of allergy vaccines on lung mechanics

Application specialist to set-up a model of histamine-induced bronchoconstriction, and to investigate pharmacological interventions with toll-like receptor agonists in this model. Histamine-infusion and flexivent technique were applied.

Postdoctoral researcher at Karolinska Institutet, Stockholm, Sweden, within the “Osher Initiative for Research on Severe Asthma at Karolinska Institutet” at the Department of Medicine, Mast Cell Biology group, headed by Gunnar Nilsson, and the Centre for Allergy Research, headed by Sven-Erik Dahlén Stipend for postdoctoral studies by the Bernard Osher Foundation/ American Asthma Foundation >> Within the Osher Initiative, the specific project investigates the role of mast cells in the pathogenesis and pathology of severe asthma. To understand disease mechanisms more in detail adequate models are developed and asthma characteristics are assessed

Postdoctoral researcher at the Helmholtz Centre for Infection Research, Braunschweig, Germany, Department of Vaccinology and Applied Microbiology, headed by Carlos A. Guzman>> The work aimed to elucidate the immunomodulatory capacity of adjuvants and their potential use in vaccine development. Moreover, the group focuses on mucosal immune reactions and mucosal administrations of vaccines

Postdoctoral researcher at Hannover Medical School, Hannover, Germany, Junior Research Group headed by Anna-Maria Dittrich, Collaborative Research Centre 587 “Immune reactions of the lung in infection and allergy”>> The project investigated the mechanisms of polysensitisations to various antigens. Focus was set on the role of IL-4 in this context, as well as on ultrafine and fine particles and gastro-intestinal manifestations of allergic disorders

Graduate Research Assistant at the Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany, Department of Immunology, Allergology and Immunotoxicology, headed by Armin Braun Stipend of the Graduate School 705.2 of the German Research Council "Pathophysiological animal models – functional and genetical analyzes", located at Hannover Medical School, Germany.The experimental work was performed in the Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover>> The thesis aimed to establish and validate a models of asthma, which should overcome limitations of existing models and resemble clinical pathology more closely in regards of relevant allergens, sensitisation routes and chronicity of the inflammation. Moreover, this work focused on modulation and prevention of allergic airway inflammation by synthetic toll-like receptor agonists. For this purpose the inflammatory response and changes of the airway wall architecture were investigated, as well as induction of regulatory T cells and the phenotype of dendritic cells

Undergraduate Research Assistant at the Fraunhofer Institute of Toxicology and Experimental Medicine, Department of Immunology, Allergology and Immunotoxicology, headed by Armin Braun, Hannover, Germany and Institute for Peptide Research/IPF Pharmaceuticals, headed by Wolf Georg Forssmann, Hannover, GermanyDiploma thesis "Effects of a CCR3 agonist in a murine asthma model” >> Investigation of asthma preventing effects of a chemokine receptor agonist